Don’t Miss

Don't Miss

Meet the 2019 STAT Wunderkinds

By STAT

Fortune telling
Don't Miss

What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets

By Sharon Begley

Don't Miss

The 23 best health and science books to read this summer

By Sarah Mupo

Beach reading
Don't Miss

We want your pick for the best health and science books to read this summer

By STAT staff

Nothing to Sneeze At: Inspiration and Respiration in a Dish
Don't Miss

Peering inside life’s microworld: MIT’s 2019 image award winners

By Sharon Begley

Don't Miss

Vote now: Pick the best ideas in biomedical science

By STAT

Don't Miss

Here are the contenders for STAT Madness 2019. Voting begins Monday

By Gideon Gil

Iowa Baby Brothers
Don't Miss

With time ticking away, clinicians scramble to save newborn twins from the disease that took their brother

By Rebecca Robbins

MGH Marijuana test
Don't Miss

STAT’s most memorable photos of 2018

By Alissa Ambrose

New York Newsstand
Don't Miss

We wish we’d written that: STAT staffers share their favorite stories of 2018

By STAT staff

Fatal error illustration
Don't Miss

Font of despair: In the fierce competition for science funding, even a typeface glitch can be fatal

By Eric Boodman

Don't Miss

Meet the 2018 STAT Wunderkinds

By STAT

Don't Miss

8 movies that really got science wrong

By STAT staff

Don't Miss

The 39 best health and science books to read this summer

By Sarah Mupo

Don't Miss

BIO in 30: A new biotech from Gates, Bradner on data science, & bienvenue à Cambridge

By Helen Branswell, Adam Feuerstein, and Damian Garde

Don't Miss

BIO in 30: The mechanics of drug prices, a new world record, & a very Canadian table hockey game

By Damian Garde and Rebecca Robbins

Don't Miss

BIO in 30: Combating sepsis, questioning Right to Try, & the existential dread of a mid-level exec

By Helen Branswell, Adam Feuerstein, and Rebecca Robbins

Don't Miss

BIO in 30: Knock on ‘fast followers,’ all about Hong Kong, & Sculley’s next stop

By Casey Ross and Rebecca Robbins

Don't Miss

ASCO in 30: Wall Street’s reaction & patient-reported outcomes

By Sharon Begley and Adam Feuerstein

Don't Miss

BIO’s back in Boston: What to look out for on Monday

By Damian Garde

Don't Miss

ASCO in 30: Immunotherapy controversy & less is just as good

By Sharon Begley and Adam Feuerstein

Don't Miss

ASCO in 30: 5-year Keytruda data & winners and losers

By Sharon Begley and Adam Feuerstein

Don't Miss

ASCO in 30: So it begins & the best health care system

By Sharon Begley and Adam Feuerstein

Summer Reading
Don't Miss

We want your pick for the best health and science books to read this summer

By STAT staff

In the Lab

Shot through with microbes: How our bodies adapt to a hidden world of bacteria

By Carl Zimmer

Neil Hayward 01
Don't Miss

A career in biotech brought success. Then the birds came calling

By Eric Boodman

Play
Don't Miss

Watch: “Runnin’”: a new documentary from STAT

By Alex Hogan

Eric Lander
Don't Miss

As Twitter explodes, Eric Lander apologizes for toasting James Watson

By Sharon Begley

Play
Don't Miss

Watch: Bill Gates the philanthropist is also Bill Gates the movie buff

By Rick Berke

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy